Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor
Abstract The current paradigm of cancer medicine focuses on patient‐ and/or cancer‐specific treatments, which has led to continuous progress in the development of patient representatives (e.g., organoids) and cancer‐targeting carriers for drug screening. As breakthrough concepts, i) living cancer ti...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Wiley
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e8e6201eb435440cbaab6765c1b052e1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|